Since 1978, Par Pharmaceutical has been at the forefront of developing, manufacturing, marketing and distributing safe, innovative and read more
Par Pharmaceuticals VP of Investor Relations Salary
The average Par Pharmaceuticals VP of Investor Relations earns an estimated $126,213 annually. Par Pharmaceuticals' VP of Investor Relations compensation is $5,195 less than the US average for a VP of Investor Relations.
Last updated 4 years ago.
$77k
$120k
$129k
$225k
$126,213
Average Compensation
- $126,213
- avg. base
VP of Investor Relations Salaries at Par Pharmaceuticals
Compensation at Par Pharmaceuticals by Department
How VPs of Investor Relations at Par Pharmaceuticals Rate Their Compensation
The majority of VPs of Investor Relations at Par Pharmaceuticals believe they're compensated fairly. The vast majority (100%) of VPs of Investor Relations at Par Pharmaceuticals are satisfied with their benefits. See more compensation ratings at Par Pharmaceuticals
VP of Investor Relations Salaries at Similar Size Companies
×